Brief: Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction Of P. gingivalis Infection & Slowing Of Alzheimer’S Disease Progression

IRulya Therapeutics

26/10/2021 21:00

Oct 26 (Reuters) - Cortexyme Inc:
    * CORTEXYME REPORTS GAIN TRIAL DATA DEMONSTRATED
RELATIONSHIP
BETWEEN REDUCTION OF P. GINGIVALIS INFECTION & SLOWING OF
ALZHEIMER’S DISEASE PROGRESSION
    * CORTEXYME - SUBGROUPS REPRESENTING UP TO HALF
THE PARTICIPANTS
BASED ON P. GINGIVALIS INFECTION LEVEL SHOWED ABOUT 50% SLOWING
OF COGNITIVE DECLINE
    * CORTEXYME - IN OVERALL POPULATION, CO-PRIMARY ENDPOINTS OF
ADAS-COG11 AND ADCS-ADL WERE NOT MET
    * CORTEXYME - ENGAGING WITH REGULATORS, MEDICAL COMMUNITY,
PATIENT
ADVOCACY GROUPS, OTHER STAKEHOLDERS TO ADVANCE DEVELOPMENT OF
ATUZAGINSTAT & COR588
    * CORTEXYME - MOST ADVERSE EVENTS IN GAIN TRIAL WERE MILD TO
MODERATE IN SEVERITY


Further company coverage:  CRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))